Pfizer Inc Virtual Investor Day: Day 2 Transcript
Welcome back, and thank you for joining us this morning for part 2 of Investor Day, where we will cover the remainder of our key R&D programs. Today, we'll hear from our immunology and inflammation, oncology and rare disease teams, and then we'll end with a segment on our COVID vaccine and antiviral programs.
As a reminder, presentations at today's session include forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects and expectations for our product pipeline, in-line products and product candidates. By their nature, all statements about future events and expectations for our pipeline products are forward-looking. Each forward-looking statement contained in these presentations is subject to risks and uncertainties that could cause actual results to differ materially from those in such statements. Additional information regarding these factors appears in the slide entitled Forward-Looking Statements and Other Notices and under Risk Factors in our 10-K and 10-Qs.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
